About
O2M Technologies is a Chicago-based company that specializes in advanced oxygen imaging technology for biomedical applications, particularly in cancer research and regenerative medicine. The company is recognized for its patented inversion recovery pulsed electron paramagnetic resonance oxygen imaging (EPROI) technology, which creates fast, three-dimensional oxygen maps of tissues. The flagship product, the JIVA-25, is the first dedicated preclinical oxygen imager designed for both in vitro and in vivo measurements. This instrument is widely used in preclinical cancer studies and regenerative medicine to assess oxygen levels essential for cell growth and survival. O2M also operates the Oxygen Measurement Core service facility, which supports various oxygen imaging studies and collaborates with organizations like JDRF. O2M Technologies serves a range of customers in biomedical research, including academic institutions and companies focused on preclinical studies. The leadership team, led by CEO Dr. Mrignayani Kotecha, brings expertise in physics, bioengineering, and biomedical sciences to advance the application of oxygen imaging in medicine.
Technologies
Keywords
Company Information
-
Employees 10
-
Founded 2017
Location
2201 W Campbell Park Dr, Chicago, Illinois, United States, 60612-3501
